Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

about

Safety of percutaneous dilatational tracheostomy in patients on extracorporeal lung support.The science and art of medicine.

P2860

Q46273048-8E3E60DD-5638-4469-92F6-7FFD7B947161 Q48256626-6A082FC0-120C-4471-A777-0B5E9E1BC6DB

P2860

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

Item

http://www.wikidata.org/entity/Q44726489

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@en

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@nl

type

Item

label

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@en

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@nl

prefLabel

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@en

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@nl

P1476

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

@en

P2093

A Vats

http://www.w3.org/2001/XMLSchema#string

M Heard

http://www.w3.org/2001/XMLSchema#string

M R Rigby

http://www.w3.org/2001/XMLSchema#string

P Kamat

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review.

Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.

Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.

Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.

Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation.

Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.

rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.

Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation*

P304

201-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0267659112469549

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23201816

http://www.w3.org/2001/XMLSchema#string

P921

extracorporeal membrane oxygenation

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

about

P2860

P2860

Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921